Roles of Thromboxane Receptor Signaling in Enhancement of Lipopolysaccharide-Induced Lymphangiogenesis and Lymphatic Drainage Function in Diaphragm.


Journal

Arteriosclerosis, thrombosis, and vascular biology
ISSN: 1524-4636
Titre abrégé: Arterioscler Thromb Vasc Biol
Pays: United States
ID NLM: 9505803

Informations de publication

Date de publication:
04 2021
Historique:
pubmed: 12 2 2021
medline: 2 6 2021
entrez: 11 2 2021
Statut: ppublish

Résumé

[Figure: see text].

Identifiants

pubmed: 33567865
doi: 10.1161/ATVBAHA.120.315507
doi:

Substances chimiques

Lipopolysaccharides 0
Receptors, Thromboxane A2, Prostaglandin H2 0
Vascular Endothelial Growth Factor C 0
Vascular Endothelial Growth Factor D 0
Vegfd protein, mouse 0
vascular endothelial growth factor C, mouse 0
Thromboxane A2 57576-52-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1390-1407

Auteurs

Hiromi Matsuda (H)

Department of Molecular Pharmacology, Graduate School of Medical Sciences (H.M., Y.I., K.H., S.T., T.I., S.N., M.M.), School of Medicine, Kitasato University, Sagamihara, Kanagawa, Japan.
Department of Pharmacology (H.M., Y.I., K.H., S.T., M.M.), School of Medicine, Kitasato University, Sagamihara, Kanagawa, Japan.
Department of Anesthesiology (H.M., S.T., C.K., H.O.), School of Medicine, Kitasato University, Sagamihara, Kanagawa, Japan.

Yoshiya Ito (Y)

Department of Molecular Pharmacology, Graduate School of Medical Sciences (H.M., Y.I., K.H., S.T., T.I., S.N., M.M.), School of Medicine, Kitasato University, Sagamihara, Kanagawa, Japan.
Department of Pharmacology (H.M., Y.I., K.H., S.T., M.M.), School of Medicine, Kitasato University, Sagamihara, Kanagawa, Japan.

Kanako Hosono (K)

Department of Molecular Pharmacology, Graduate School of Medical Sciences (H.M., Y.I., K.H., S.T., T.I., S.N., M.M.), School of Medicine, Kitasato University, Sagamihara, Kanagawa, Japan.
Department of Pharmacology (H.M., Y.I., K.H., S.T., M.M.), School of Medicine, Kitasato University, Sagamihara, Kanagawa, Japan.

Seri Tsuru (S)

Department of Molecular Pharmacology, Graduate School of Medical Sciences (H.M., Y.I., K.H., S.T., T.I., S.N., M.M.), School of Medicine, Kitasato University, Sagamihara, Kanagawa, Japan.
Department of Pharmacology (H.M., Y.I., K.H., S.T., M.M.), School of Medicine, Kitasato University, Sagamihara, Kanagawa, Japan.
Department of Anesthesiology (H.M., S.T., C.K., H.O.), School of Medicine, Kitasato University, Sagamihara, Kanagawa, Japan.

Tomoyoshi Inoue (T)

Department of Molecular Pharmacology, Graduate School of Medical Sciences (H.M., Y.I., K.H., S.T., T.I., S.N., M.M.), School of Medicine, Kitasato University, Sagamihara, Kanagawa, Japan.

Shuji Nakamoto (S)

Department of Molecular Pharmacology, Graduate School of Medical Sciences (H.M., Y.I., K.H., S.T., T.I., S.N., M.M.), School of Medicine, Kitasato University, Sagamihara, Kanagawa, Japan.
Center for Innovation in Immunoregulation Technology and Therapeutics, Kyoto University Graduate School of Medicine, Japan (S.N.).

Chie Kurashige (C)

Department of Anesthesiology (H.M., S.T., C.K., H.O.), School of Medicine, Kitasato University, Sagamihara, Kanagawa, Japan.

Masanori Hirashima (M)

Division of Pharmacology, Graduate School of Medical and Dental Sciences, Niigata University, Japan (M.H.).

Shuh Narumiya (S)

Center for Innovation in Immunoregulation Technology and Therapeutics, Kyoto University Graduate School of Medicine, Japan (S.N.).

Hirotsugu Okamoto (H)

Department of Anesthesiology (H.M., S.T., C.K., H.O.), School of Medicine, Kitasato University, Sagamihara, Kanagawa, Japan.

Masataka Majima (M)

Department of Molecular Pharmacology, Graduate School of Medical Sciences (H.M., Y.I., K.H., S.T., T.I., S.N., M.M.), School of Medicine, Kitasato University, Sagamihara, Kanagawa, Japan.
Department of Pharmacology (H.M., Y.I., K.H., S.T., M.M.), School of Medicine, Kitasato University, Sagamihara, Kanagawa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH